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adherent culture conditions. In contrast, 
Perego et al. (2010) found that MDR1 
mRNA was not differentially expressed 
in melanospheres compared with adher-
ent melanoma cultures.
In aggregate, the currently avail-
able evidence does not support a sig-
nificant or preferential correlation of a 
particular in vitro melanoma growth 
pattern (i.e., spheroid or adherent 
growth) with known melanoma CSC 
molecular phenotypes or functions. 
These results challenge the utility of 
the melanosphere assay as a surrogate 
tool for enriching CSCs in human 
malignant melanoma and underline 
the importance of molecularly defined 
MMICs for CSC-focused diagnostic and 
therapeutic investigations.
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Vexed by Red-Headed Conundrums
Jonathan L. Rees1
Reduced function alleles of the melanocortin 1 receptor (MC1R) lead to red 
hair, freckling, and sun sensitivity. They are also associated with an increased 
risk of skin cancer. But what pathways link gene variants with the cancer phe-
notype? In this issue, Robinson et al. describe their use of mouse transgenics 
to demonstrate that the MC1R signaling pathway influences cancer risk via 
mechanisms in addition to pigmentation.
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“…and then off to violin-land, 
where all is sweetness...and there 
are no red-headed clients to vex us 
with their conundrums.”
—Sherlock Holmes,  
in “The Red-Headed League”
In Arthur Conan Doyle’s Sherlock 
Holmes story “The Red-Headed 
League,” the central character, Jabez 
Wilson, has fiery red hair. Ensnared by 
bank robbers, he is persuaded to leave 
his shop so that he can take up gener-
ously paid work elsewhere. Curiously, 
this well-paid work is open only to 
those with red hair, and the work itself 
appears to serve no useful function. 
The reader is left wondering what 
aspect of red hair is critical to the 
logic of the story, but the explanation 
is mundane. We learn that Wilson’s 
shop is situated next to a bank, and 
the villains want him out of the way so 
that they can tunnel into the bank next 
door. The story could therefore have 
focused on any of Wilson’s character-
istics, and red hair was used merely as 
a marker.
What of red hair and skin cancer? 
We know that most forms of skin can-
cer are more common in individu-
als with red hair and pale skin (Rees, 
2004). Does causality run from altered 
pigmentation to skin cancer, or, as in 
the story, is red hair merely a visible 
marker for some other characteristic? 
The paper by Healy’s group (Robinson 
et al., 2010, this issue) provides us 
with yet more reasons to admit that 
the link between red hair and skin 
cancer still vexes.
the evolution of human pigmentation
Human pigmentation attracts great 
interest, and not only because of its 
link with skin disease. Variation in 
human skin and hair color is one of 
the most striking polymorphic traits 
of mankind (Rees, 2004). Covariation 
of skin color, ancestry, and geography 
is obvious to most observers and has 
played a key role in human history—
for good and bad. If we were to pré-
cis human evolution over the past 
500,000 years, it would perhaps read 
as follows.
Following climate change, our 
ancestors were forced to move from 
the forest to the savannah. The need 
to hunt meant that endurance exer-
cise became essential—we may not 
have been able to outsprint other 
mammals, but humans can still out-
run a horse over marathon distances 
in a warm climate. We were therefore 
able to track and hunt prey over large 
distances. We owe much of this abil-
ity to the way our skin is designed. 
Humans are covered by 3 to 5 million 
eccrine glands, and we are astonish-
ingly capable of losing body heat gen-
erated by physical activity. However, 
sweating was more efficient if evapo-
ration could take place unimpeded 
by hair; thus humans became—to use 
the cliché—naked. This in turn led 
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to another design problem: how was 
the now-naked skin to be protected 
against the mutagenic effects of UVR? 
Pigment, now primarily in the interfol-
licular skin, was part of the solution.
As humans moved out of Africa, a 
second pigmentary change occurred. 
Skin lightened progressively, and a 
range of hair colors was seen, includ-
ing blonde and red. The conventional 
explanation of skin lightening was the 
requirement to boost vitamin D levels 
in northern latitudes, especially for 
those who ate a predominantly cere-
al-based (and hence vitamin D–poor) 
diet, and the diminution of the need 
for protection against the hazards of 
UVR. This makes a nice hypothesis, 
but is it true? And how, in a histori-
cal subject such as human evolution, 
can we find out more? One promis-
ing approach is to identify the genes 
involved in human pigmentation, 
study their sequence diversity across 
primates and modern human popu-
lations, and literally work backward 
to imagine what forces were shaping 
them (Harding et al., 2000). This all 
assumes that we know how pigment 
genes work, and it is this caveat that 
makes the paper from Healy’s group 
(Robinson et al., 2010) so interesting.
Why and how is red hair associated 
with skin cancer?
Much, if not most, of what we know 
about the genetics of human pigmen-
tation has come from insights afforded 
from the study in mice of coat-color 
genetics. The first gene that could 
account for what we (somewhat sub-
jectively) define as normal variation in 
humans was the melanocortin 1 recep-
tor (MC1R). Cloned in the mouse by 
Roger Cone’s group in 1993, the mc1r 
was a cell surface G-coupled recep-
tor located chiefly on the outer cell 
membrane of melanocytes (reviewed 
in Rees, 2004). The receptor has some 
intrinsic activity, but interaction with 
the peptide ligand α-melanocyte-
stimulating hormone leads, via 
c-AMP signaling, to a change in 
transcriptional control of various pig-
mentation genes. At the level of the 
phenotype, signaling through this 
pathway leads to an increase in the 
ratio of eumelanin (brown or black 
melanin) to pheomelanin (yellow or 
red melanin); inhibition of the path-
way resulting from mc1r mutation 
leads to a relative overproduction 
of pheomelanin. Work in humans 
quickly demonstrated that sequence 
variation at the MC1R was common 
in European populations (Valverde et 
al., 1995, 1996) and that, assuming 
an autosomal model, a group of par-
ticular variants cosegregated with red 
hair, pale skin, and freckling in family 
studies (Rees, 2004).
Perhaps because red hair (and the 
MC1RI) was the first human trait for 
which crime-scene DNA could use-
fully predict a major visible pheno-
type, interest in the gene has been 
high. More than half of the UK popula-
tion carries variants of the MC1R, with 
over 100 variants identified to date 
(Rees, 2004). However, if we look at 
modern African populations, we see 
little nonsynonymous variation; rath-
er, the gene appears under functional 
constraint (Harding et al., 2000). Out 
of Africa, there is either release from 
this constraint or selection for alleles 
with diminished function. At this level 
of description, the story appears quite 
straightforward. We know that MC1R 
is a key factor determining the ratio of 
eumelanin to pheomelanin; a reduc-
tion in this ratio (at least in hair) is asso-
ciated with cutaneous sun sensitivity 
and a greater risk of skin cancer. MC1R 
variation has therefore been driven by 
evolution favoring those with pale skin 
in geographical areas with low UVR. Is 
there anything left to know? The work 
of Healy and colleagues (Robinson et 
al., 2010) and a number of other recent 
papers suggest that there is.
The authors use the power of mouse 
genetics to address a remarkably simple 
hypothesis. If MC1R exerts its effects via 
pigmentation, then in mice that pro-
duce no pigment, we should not see any 
phenotypic effect of MC1R. And this is 
exactly what Healy’s group did not see. 
Using transgenics generated using bac-
terial artificial chromosomes, and as a 
readout the number of UVR-induced 
p53-positive clones, the authors found 
that the presence of human MC1R does 
indeed alter the response of albino mice 
to repeated irradiation. (In nonalbino 
mice, they also show that MC1R seems 
to diminish the number of clones but, 
frustratingly, did not analyze the data in 
a way that this reader would have pre-
ferred.) So, to spell it out, in mice that 
have little or no pigment, MC1R still 
exerts a phenotypic effect. If we wish 
to explain the high rates of skin can-
cer associated with red hair in terms of 
a shift in the ratio of different melanin 
types, why would we still see an effect 
in the absence of melanin? If we return 
to the canvas of human evolution, is 
the covariation among MC1R diver-
sity, pigmentation, and sun sensitivity 
causal? Alternatively, has hair and skin 
color acted simply as a confounder—a 
marker—as in the story of Jabez Wilson?
It would be easy to wonder whether 
this unexpected result was that of some 
artifact. Robinson et al. (2010) have 
used human MC1R in a murine system, 
but mouse and human pigmentation 
show important differences, and the 
physiology of UVR seems to differ 
between the species. Also, the authors 
do not discount a role for pigmentation 
in photoprotection, thinking instead 
that more than one pathway is oper-
ating. But what makes these results so 
intriguing is that they are in keeping 
with the findings of several other, dis-
parate papers, suggesting that some 
of us were indeed dazzled by what 
seemed obvious rather than the truth.
The first paper linking MC1R and 
human cancer showed that the effect 
of MC1R appeared independent of 
skin type and, by implication, skin 
pigmentation (Valverde et al., 1996). 
A range of larger studies on melanoma 
and nonmelanoma skin cancer argued 
that the effects of MC1R were partially 
dependent on pigmentation but that pig-
mentation could not explain all of the 
association observed between MC1R and 
cancer risk. There are technical reasons 
that explain why some of the variance 
relating to pigmentation might not be 
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The effects of MC1R 
are not limited to 
determining the ratio 




captured in the statistical models, leaving 
a residual effect of genotype apparently 
independent of MC1R. However, this 
viewpoint looks increasingly wide of the 
mark. Various groups have subsequently 
suggested that MC1R influences DNA 
damage and DNA repair in ways that 
are not explicable in terms of pigmen-
tary status (Böhm et al., 2005; Hauser 
et al., 2006). More recently, Greg Barsh, 
on the basis of gene-array experiments 
performed on neonatal mouse skin, 
demonstrated that the pattern of gene 
expression differs in mice depending on 
mc1r status (April and Barsh, 2007), and 
Landi et al. (2006) showed that there is a 
curious and consistent relation between 
MC1R status and the presence of BRAF 
mutations in melanoma. All these studies 
are in keeping with the idea that MC1R 
affects a range of key regulatory path-
ways involved in cell cycle control and 
apoptosis, not only in melanocytes but 
also in the surrounding keratinocytes. To 
this evidence from diverse sources must 
now be added the work of Robinson et 
al. (2010).
Several years ago, Jeff Mogil was 
mapping quantitative trait loci in mice 
associated with responses to pain (Mogil 
et al., 2003). Surprisingly, one locus that 
seemed important turned out to be the 
mc1r. Subsequent work has extended 
these studies into humans, although the 
picture at present remains unclear, with 
some effects seen only in females and 
the effects restricted to certain types of 
pain. As yet, we have little idea of any 
mechanism to account for these puz-
zling results. But again, MC1R seems to 
be doing things we hadn’t imagined only 
a short while ago. Pigment in nature is 
often used either to attract attention (as 
in sexual behavior) or to do the opposite, 
i.e., to act as camouflage. MC1R plays 
a key role in determining the type and 
extent of human pigmentation. Some of 
us have perhaps been slow to see exact-
ly what this MC1R-associated pigment 
was concealing.
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Two-Way Traffic on the Bridge  
from Innate to Adaptive Immunity
Stephen E. Ullrich1
Conventional wisdom suggests that information is usually transmitted from the 
dendritic cell (DC) to the T cell.  In this issue, Schwarz and Schwarz demonstrate 
that UV-induced T regulatory cells (Tregs) can influence the biology of naïve DC. 
They report that IL-10-secreting Tregs prime DC to activate additional Tregs 
when injected into naïve mice.  It may be possible to use DCs that have been 
“educated” by Tregs to induce immune tolerance in vivo.  
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Most introductory immunology courses 
for first-year medical and/or graduate 
students follow a fairly predictable path. 
First we introduce the players, i.e., the 
cells and molecules that constitute the 
immune system. We then introduce the 
processes that differentiate “self” from 
“nonself,” thereby protecting against 
microbial infection. Innate and adap-
tive immune reactions are introduced 
early in the class, and inevitably stu-
dents are told that dendritic cells (DCs) 
are the bridge between the innate and 
adaptive immune responses. We then 
describe how DCs process foreign anti-
gens and present them to T cells. We 
discuss costimulatory molecules and 
the immune synapse formed between 
DCs and T cells, as well as the genera-
tion of helper and effector cells that 
ultimately drive adaptive immunity. For 
the most part, and usually for the sake 
of simplicity, we describe a one-way 
pathway of information from DCs to T 
cells.
For several years, however, immu-
nologists have realized that information 
flowing from T cells to DCs can influ-
ence DC function. For example, 
Shreedhar and colleagues (1999) report-
ed that T-cell function is critical for DC 
maturation and migration in vivo. The 
